NCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
Clinical Trials
17 trialsNCT06390111 2024-11-22
ABLE-42
Ferring Pharmaceuticals
Phase 4 Withdrawn
NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
NCT05183139 2022-05-03
US MM-7
Takeda
Phase 4 Withdrawn
NCT01288625 2021-11-17
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Sun Pharmaceutical Industries Limited
Phase 4 Withdrawn
NCT00858754 2019-11-29
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
Bausch Health Americas, Inc.
Phase 4 Withdrawn
NCT03988114 2019-09-06
proMONARCH
Eli Lilly and Company
Phase 4 Withdrawn
NCT01605981 2017-04-20
MACS1881
Novartis
Phase 4 Withdrawn
NCT00510627 2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4 Withdrawn
NCT00774241 2016-11-02
PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Withdrawn
NCT01156961 2016-11-02
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Hoffmann-La Roche
Phase 4 Withdrawn
NCT02761083 2016-06-10
OPHTHALNOQ
Aesculap AG
Phase 4 Withdrawn
NCT01903850 2016-02-02
TAO
CSA Medical, Inc.
Phase 4 Withdrawn
NCT00785694 2015-04-24
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
GE Healthcare
Phase 4 Withdrawn
NCT00242528 2015-04-14
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
Novartis
Phase 4 Withdrawn
NCT02101164 2015-02-18
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Amgen
Phase 4 Withdrawn
NCT00711204 2012-12-10
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Eisai Inc.
Phase 4 Withdrawn